METHODE ELECTRONICS INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that METHODE ELECTRONICS INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Apr 28, 2018 | $908.30M | Jun 21, 2018 |
| FY2017 | Apr 29, 2017 | $816.50M | Jun 22, 2017 |
| FY2016 | Apr 30, 2016 | $809.10M | Jun 23, 2016 |
| FY2015 | May 2, 2015 | $881.10M | Jun 25, 2015 |
| FY2014 | May 3, 2014 | $772.80M | Jun 26, 2014 |
| FY2014 | Apr 27, 2013 | $519.80M | Jun 26, 2014 |
| FY2014 | Apr 28, 2012 | $465.10M | Jun 26, 2014 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 3, 2025 | $1.05B | Jul 9, 2025 |
| FY2025 | Apr 27, 2024 | $1.11B | Jul 9, 2025 |
| FY2025 | Apr 29, 2023 | $1.18B | Jul 9, 2025 |
| FY2022 | Apr 30, 2022 | $288.70M | Jun 23, 2022 |
| FY2022 | Jan 29, 2022 | $291.60M | Jun 23, 2022 |
| FY2022 | Oct 30, 2021 | $295.50M | Jun 23, 2022 |
| FY2022 | Jul 31, 2021 | $287.80M | Jun 23, 2022 |
| FY2022 | May 1, 2021 | $301.00M | Jun 23, 2022 |
| FY2022 | Jan 30, 2021 | $295.30M | Jun 23, 2022 |
| FY2022 | Oct 31, 2020 | $300.80M | Jun 23, 2022 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Apr 28, 2018 | $249.00M | Jun 21, 2018 |
| FY2018 | Jan 27, 2018 | $228.00M | Jun 21, 2018 |
| FY2018 | Oct 28, 2017 | $230.10M | Jun 21, 2018 |
| FY2018 | Jul 29, 2017 | $201.20M | Jun 21, 2018 |
| FY2017 | Apr 29, 2017 | $219.70M | Jun 22, 2017 |
| FY2017 | Jan 28, 2017 | $195.60M | Jun 22, 2017 |
| FY2017 | Oct 29, 2016 | $209.30M | Jun 22, 2017 |
| FY2017 | Jul 30, 2016 | $191.90M | Jun 22, 2017 |
| FY2016 | Apr 30, 2016 | $212.80M | Jun 23, 2016 |
| FY2016 | Jan 30, 2016 | $184.60M | Jun 23, 2016 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 3, 2025 | $163.40M | Jul 9, 2025 |
| FY2025 | Apr 27, 2024 | $178.80M | Jul 9, 2025 |
| FY2025 | Apr 29, 2023 | $264.10M | Jul 9, 2025 |
| FY2022 | Apr 30, 2022 | $54.90M | Jun 23, 2022 |
| FY2022 | Jan 29, 2022 | $69.10M | Jun 23, 2022 |
| FY2022 | Oct 30, 2021 | $69.20M | Jun 23, 2022 |
| FY2022 | Jul 31, 2021 | $71.70M | Jun 23, 2022 |
| FY2022 | May 1, 2021 | $75.60M | Jun 23, 2022 |
| FY2022 | Jan 30, 2021 | $72.60M | Jun 23, 2022 |
| FY2022 | Oct 31, 2020 | $80.80M | Jun 23, 2022 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 3, 2025 | ($62.60M) | Jul 9, 2025 |
| FY2025 | Apr 27, 2024 | ($123.30M) | Jul 9, 2025 |
| FY2025 | Apr 29, 2023 | $77.10M | Jul 9, 2025 |
| FY2022 | Apr 30, 2022 | $16.20M | Jun 23, 2022 |
| FY2022 | Jan 29, 2022 | $29.40M | Jun 23, 2022 |
| FY2022 | Oct 30, 2021 | $27.50M | Jun 23, 2022 |
| FY2022 | Jul 31, 2021 | $29.10M | Jun 23, 2022 |
| FY2022 | May 1, 2021 | $31.10M | Jun 23, 2022 |
| FY2022 | Jan 30, 2021 | $31.90M | Jun 23, 2022 |
| FY2022 | Oct 31, 2020 | $38.60M | Jun 23, 2022 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 3, 2025 | ($23.90M) | Jul 9, 2025 |
| FY2025 | Apr 27, 2024 | ($112.00M) | Jul 9, 2025 |
| FY2025 | Apr 29, 2023 | $90.40M | Jul 9, 2025 |
| FY2024 | Apr 30, 2022 | $111.70M | Jul 11, 2024 |
| FY2023 | May 1, 2021 | $127.90M | Jun 27, 2023 |
| FY2022 | May 2, 2020 | $147.10M | Jun 23, 2022 |
| FY2021 | Apr 27, 2019 | $106.80M | Jun 24, 2021 |
| FY2020 | Apr 28, 2018 | $118.30M | Jun 30, 2020 |
| FY2019 | Apr 29, 2017 | $110.80M | Jun 20, 2019 |
| FY2018 | Apr 30, 2016 | $109.70M | Jun 21, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 3, 2025 | $41.80M | Jul 9, 2025 |
| FY2025 | Apr 27, 2024 | $49.10M | Jul 9, 2025 |
| FY2025 | Apr 29, 2023 | $35.00M | Jul 9, 2025 |
| FY2023 | Apr 30, 2022 | $35.70M | Jun 27, 2023 |
| FY2024 | May 1, 2021 | $35.70M | Jul 11, 2024 |
| FY2022 | May 2, 2020 | $34.90M | Jun 23, 2022 |
| FY2021 | Apr 27, 2019 | $41.20M | Jun 24, 2021 |
| FY2020 | Apr 28, 2018 | $37.90M | Jun 30, 2020 |
| FY2019 | Apr 29, 2017 | $27.80M | Jun 20, 2019 |
| FY2018 | Apr 30, 2016 | $27.80M | Jun 21, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 3, 2025 | $163.90M | Jul 9, 2025 |
| FY2025 | Apr 27, 2024 | $160.90M | Jul 9, 2025 |
| FY2025 | Apr 29, 2023 | $154.90M | Jul 9, 2025 |
| FY2024 | Apr 30, 2022 | $134.10M | Jul 11, 2024 |
| FY2023 | May 1, 2021 | $126.90M | Jun 27, 2023 |
| FY2022 | May 2, 2020 | $116.80M | Jun 23, 2022 |
| FY2021 | Apr 27, 2019 | $142.90M | Jun 24, 2021 |
| FY2020 | Apr 28, 2018 | $115.70M | Jun 30, 2020 |
| FY2019 | Apr 29, 2017 | $105.20M | Jun 20, 2019 |
| FY2018 | Apr 30, 2016 | $100.80M | Jun 21, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 3, 2025 | $26.40M | Jul 9, 2025 |
| FY2025 | Apr 27, 2024 | $47.50M | Jul 9, 2025 |
| FY2025 | Apr 29, 2023 | $132.80M | Jul 9, 2025 |
| FY2024 | Apr 30, 2022 | $98.80M | Jul 11, 2024 |
| FY2023 | May 1, 2021 | $179.80M | Jun 27, 2023 |
| FY2022 | May 2, 2020 | $140.60M | Jun 23, 2022 |
| FY2021 | Apr 27, 2019 | $102.00M | Jun 24, 2021 |
| FY2020 | Apr 28, 2018 | $117.80M | Jun 30, 2020 |
| FY2019 | Apr 29, 2017 | $145.20M | Jun 20, 2019 |
| FY2018 | Apr 30, 2016 | $110.70M | Jun 21, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 3, 2025 | $41.60M | Jul 9, 2025 |
| FY2025 | Apr 27, 2024 | $50.20M | Jul 9, 2025 |
| FY2025 | Apr 29, 2023 | $42.00M | Jul 9, 2025 |
| FY2024 | Apr 30, 2022 | $38.00M | Jul 11, 2024 |
| FY2023 | May 1, 2021 | $24.90M | Jun 27, 2023 |
| FY2022 | May 2, 2020 | $45.10M | Jun 23, 2022 |
| FY2021 | Apr 27, 2019 | $49.80M | Jun 24, 2021 |
| FY2020 | Apr 28, 2018 | $47.70M | Jun 30, 2020 |
| FY2019 | Apr 29, 2017 | $22.40M | Jun 20, 2019 |
| FY2018 | Apr 30, 2016 | $23.20M | Jun 21, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 3, 2025 | $1.31B | Jul 9, 2025 |
| FY2025 | Apr 27, 2024 | $1.40B | Jul 9, 2025 |
| FY2025 | Apr 29, 2023 | $1.58B | Jul 9, 2025 |
| FY2024 | Apr 30, 2022 | $1.39B | Jul 11, 2024 |
| FY2023 | May 1, 2021 | $1.47B | Jun 27, 2023 |
| FY2022 | May 2, 2020 | $1.37B | Jun 23, 2022 |
| FY2021 | Apr 27, 2019 | $1.23B | Jun 24, 2021 |
| FY2020 | Apr 28, 2018 | $915.90M | Jun 30, 2020 |
| FY2019 | Apr 29, 2017 | $704.00M | Jun 20, 2019 |
| FY2018 | Apr 30, 2016 | $655.90M | Jun 21, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 3, 2025 | $612.50M | Jul 9, 2025 |
| FY2025 | Apr 27, 2024 | $637.50M | Jul 9, 2025 |
| FY2024 | Apr 29, 2023 | $626.20M | Jul 11, 2024 |
| FY2023 | Apr 30, 2022 | $475.30M | Jun 27, 2023 |
| FY2022 | May 1, 2021 | $549.00M | Jun 23, 2022 |
| FY2021 | May 2, 2020 | $587.20M | Jun 24, 2021 |
| FY2020 | Apr 27, 2019 | $542.00M | Jun 30, 2020 |
| FY2019 | Apr 28, 2018 | $285.90M | Jun 20, 2019 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 3, 2025 | $693.30M | Jul 9, 2025 |
| FY2025 | Apr 27, 2024 | $766.00M | Jul 9, 2025 |
| FY2025 | Apr 29, 2023 | $941.80M | Jul 9, 2025 |
| FY2025 | Apr 30, 2022 | $913.80M | Jul 9, 2025 |
| FY2024 | May 1, 2021 | $918.00M | Jul 11, 2024 |
| FY2023 | May 2, 2020 | $783.40M | Jun 27, 2023 |
| FY2022 | Apr 27, 2019 | $689.70M | Jun 23, 2022 |
| FY2021 | Apr 28, 2018 | $630.00M | Jun 24, 2021 |
| FY2020 | Apr 29, 2017 | $541.10M | Jun 30, 2020 |
| FY2019 | Apr 30, 2016 | $470.10M | Jun 20, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 3, 2025 | $172.70M | Jul 9, 2025 |
| FY2025 | Apr 27, 2024 | $169.90M | Jul 9, 2025 |
| FY2025 | Apr 29, 2023 | $301.90M | Jul 9, 2025 |
| FY2025 | Apr 30, 2022 | $233.00M | Jul 9, 2025 |
| FY2024 | May 1, 2021 | $235.60M | Jul 11, 2024 |
| FY2023 | May 2, 2020 | $231.60M | Jun 27, 2023 |
| FY2022 | Apr 27, 2019 | $233.30M | Jun 23, 2022 |
| FY2021 | Apr 28, 2018 | $59.20M | Jun 24, 2021 |
| FY2020 | Apr 29, 2017 | $1.60M | Jun 30, 2020 |
| FY2019 | Apr 30, 2016 | $1.70M | Jun 20, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 3, 2025 | $524.20M | Jul 9, 2025 |
| FY2025 | Apr 27, 2024 | $612.30M | Jul 9, 2025 |
| FY2024 | Apr 29, 2023 | $772.70M | Jul 11, 2024 |
| FY2023 | Apr 30, 2022 | $763.90M | Jun 27, 2023 |
| FY2022 | May 1, 2021 | $746.00M | Jun 23, 2022 |
| FY2021 | May 2, 2020 | $651.90M | Jun 24, 2021 |
| FY2020 | Apr 27, 2019 | $545.20M | Jun 30, 2020 |
| FY2019 | Apr 28, 2018 | $472.00M | Jun 20, 2019 |
| FY2018 | Apr 29, 2017 | $427.00M | Jun 21, 2018 |
| FY2017 | Apr 30, 2016 | $358.60M | Jun 22, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 3, 2025 | $103.60M | Jul 9, 2025 |
| FY2025 | Apr 27, 2024 | $161.50M | Jul 9, 2025 |
| FY2024 | Apr 29, 2023 | $157.00M | Jul 11, 2024 |
| FY2023 | Apr 30, 2022 | $172.00M | Jun 27, 2023 |
| FY2022 | May 1, 2021 | $233.20M | Jun 23, 2022 |
| FY2021 | May 2, 2020 | $217.30M | Jun 24, 2021 |
| FY2020 | Apr 27, 2019 | $83.20M | Jun 30, 2020 |
| FY2019 | Apr 28, 2018 | $246.10M | Jun 20, 2019 |
| FY2019 | Apr 29, 2017 | $294.00M | Jun 20, 2019 |
| FY2019 | Apr 30, 2016 | $227.80M | Jun 20, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 3, 2025 | $317.60M | Jul 9, 2025 |
| FY2025 | Apr 27, 2024 | $330.90M | Jul 9, 2025 |
| FY2024 | Apr 29, 2023 | $306.80M | Jul 11, 2024 |
| FY2023 | Apr 30, 2022 | $210.50M | Jun 27, 2023 |
| FY2022 | May 1, 2021 | $240.10M | Jun 23, 2022 |
| FY2021 | May 2, 2020 | $352.10M | Jun 24, 2021 |
| FY2020 | Apr 27, 2019 | $292.60M | Jun 30, 2020 |
| FY2019 | Apr 28, 2018 | $53.40M | Jun 20, 2019 |
| FY2018 | Apr 29, 2017 | $27.00M | Jun 21, 2018 |
| FY2017 | Apr 30, 2016 | $57.00M | Jun 22, 2017 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 3, 2025 | (1) | Jul 9, 2025 |
| FY2025 | Apr 27, 2024 | (3) | Jul 9, 2025 |
| FY2025 | Apr 29, 2023 | 2 | Jul 9, 2025 |
| FY2022 | Apr 30, 2022 | 0 | Jun 23, 2022 |
| FY2022 | Jan 29, 2022 | 0 | Jun 23, 2022 |
| FY2022 | Oct 30, 2021 | 0 | Jun 23, 2022 |
| FY2022 | Jul 31, 2021 | 0 | Jun 23, 2022 |
| FY2022 | May 1, 2021 | 0 | Jun 23, 2022 |
| FY2022 | Jan 30, 2021 | 0 | Jun 23, 2022 |
| FY2022 | Oct 31, 2020 | 1 | Jun 23, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 3, 2025 | (1) | Jul 9, 2025 |
| FY2025 | Apr 27, 2024 | (3) | Jul 9, 2025 |
| FY2025 | Apr 29, 2023 | 2 | Jul 9, 2025 |
| FY2022 | Apr 30, 2022 | 0 | Jun 23, 2022 |
| FY2022 | Jan 29, 2022 | 0 | Jun 23, 2022 |
| FY2022 | Oct 30, 2021 | 0 | Jun 23, 2022 |
| FY2022 | Jul 31, 2021 | 0 | Jun 23, 2022 |
| FY2022 | May 1, 2021 | 0 | Jun 23, 2022 |
| FY2022 | Jan 30, 2021 | 0 | Jun 23, 2022 |
| FY2022 | Oct 31, 2020 | 1 | Jun 23, 2022 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Apr 29, 2017 | 38.13M | Jun 22, 2017 |
| FY2016 | Apr 30, 2016 | 38.18M | Jun 23, 2016 |
| FY2015 | May 2, 2015 | 39.70M | Jun 25, 2015 |
| FY2014 | May 3, 2014 | 39.26M | Jun 26, 2014 |
| FY2013 | Apr 27, 2013 | 38.46M | Jun 20, 2013 |
| FY2013 | Apr 28, 2012 | 38.38M | Jun 20, 2013 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 3, 2025 | $20.40M | Jul 9, 2025 |
| FY2025 | Apr 27, 2024 | $19.90M | Jul 9, 2025 |
| FY2025 | Apr 29, 2023 | $19.80M | Jul 9, 2025 |
| FY2024 | Apr 30, 2022 | $20.40M | Jul 11, 2024 |
| FY2023 | May 1, 2021 | $17.40M | Jun 27, 2023 |
| FY2022 | May 2, 2020 | $16.30M | Jun 23, 2022 |
| FY2021 | Apr 27, 2019 | $16.30M | Jun 24, 2021 |
| FY2020 | Apr 28, 2018 | $14.70M | Jun 30, 2020 |
| FY2019 | Apr 29, 2017 | $13.70M | Jun 20, 2019 |
| FY2018 | Apr 30, 2016 | $13.50M | Jun 21, 2018 |